Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years

Markus Hecht

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2082-216X; OpenAlex author ID A5053999765. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomi… Co-author DOI 10.1200/jco-25-03004↗
  2. Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO… Co-author DOI 10.1200/jco-24-01502↗
  3. Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. Co-author DOI 10.3892/ol.2017.7523↗
  4. Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells. Co-author DOI 10.1371/journal.pone.0130277↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rainer Fietkau · 4 shared papers, 2015–2026 · strength 0.53
  2. Sabine Semrau · 2 shared papers, 2025–2026 · strength 0.40
  3. Michael B. Ghadimi · 2 shared papers, 2025–2026 · strength 0.40
  4. Andrea Tannapfel · 2 shared papers, 2025–2026 · strength 0.40
  5. Dorota Łubgan · 2 shared papers, 2025–2026 · strength 0.40
  6. Waldemar H. Uhl · 2 shared papers, 2025–2026 · strength 0.40
  7. Henriette Golcher · 2 shared papers, 2025–2026 · strength 0.40
  8. Robert Grützmann · 2 shared papers, 2025–2026 · strength 0.40
  9. Dirk Waldschmidt · 2 shared papers, 2025–2026 · strength 0.40
  10. Anke Reinacher‐Schick · 2 shared papers, 2025–2026 · strength 0.40
  11. Helmut Oettle · 2 shared papers, 2025–2026 · strength 0.40
  12. Uwe A. Wittel · 2 shared papers, 2025–2026 · strength 0.40
  13. Stefan Hubert Boeck · 2 shared papers, 2025–2026 · strength 0.40
  14. Luitpold Valentin Distel · 2 shared papers, 2015–2018 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.